サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1783836

ヘパリン原薬の世界市場：2025年

Global Heparin API Market Research Report 2025

出版日
発行
QYResearch
ページ情報
英文 125 Pages
納期
2～3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
ヘパリン原薬の世界市場：2025年
出版日: 2025年08月05日
発行: QYResearch
ページ情報: 英文 125 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヘパリン原薬の市場規模は、2024年に12億3,000万米ドルとなりました。

同市場は、2025年から2031年の予測期間中に7.77％のCAGRで拡大し、2031年には23億米ドルに達すると予測されています。

北米のヘパリン原薬の市場規模は、2025年の4億3,149万米ドルから2031年には6億7,133万米ドルに達すると予測され、2025年から2031年の予測期間中のCAGRは7.65%になるとみられています。

アジア太平洋のヘパリン原薬の市場規模は、2025年の4億7,850万米ドルから2031年には7億9,946万米ドルに達すると予測され、2025年から2031年の予測期間中のCAGRは8.93%になるとみられています。

欧州のヘパリン原薬の市場規模は、2025年の5億3,757万米ドルから2031年には8億122万米ドルに達すると予測され、2025年から2031年の予測期間中のCAGRは6.88%になるとみられています。

ヘパリン原薬の主な世界的メーカーには、Shenzhen Hepalink Pharmaceutical、Yantai Dongcheng Pharmaceutical、Pfizer、Bioiberica、Changzhou Qianhong Biopharma、Nanjing King-friend Biochemical Pharmaceutical、Hebei Changshan Biochemical Pharmaceutical、Qingdao Jiulong Biopharmaceutical、Opocrin、Dongying Tiandong Pharmaceuticalなどがあります。2024年には、世界の上位3ベンダーが売上の約38％を占めています。

当レポートは、ヘパリン原薬の世界市場を量的・質的分析の両面から包括的に提示することで、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、ヘパリン原薬に関する十分な情報に基づいたビジネス上の意思決定を行えるようにすることを目的としています。

ヘパリン原薬の市場規模・推計・予測は、2024年を基準年とし、2020年から2031年までの期間の履歴データと予測データを売上数量（億単位）と収益（100万米ドル）で提供します。当レポートでは、世界のヘパリン原薬市場を包括的にセグメント化しています。製品タイプ別、用途別、参入企業別の地域別市場規模も掲載しています。

市場をより深く理解するために、競合情勢、主要競合企業のプロファイル、それぞれの市場ランクを掲載しています。また、技術動向や新製品開発についても論じています。

当レポートは、ヘパリン原薬メーカー、新規参入企業、本市場における産業チェーン関連企業に対し、市場全体および企業収益別、タイプ別、用途別、地域別のサブセグメントにおける収益、販売量、平均価格に関する情報を提供します。

目次

第1章 ヘパリン原薬市場概要

  • 製品定義
  • ヘパリン原薬の種類
  • 用途別ヘパリン原薬
  • 世界のヘパリン原薬市場規模予測
  • 前提と制限

第2章 ヘパリン原薬市場における競争

第3章 ヘパリン原薬市場シナリオ、地域別

  • 世界のヘパリン原薬の市場規模：2020年、2024年、2031年、地域別
  • 世界のヘパリン原薬の売上：2020年～2031年、地域別
  • 世界のヘパリン原薬の収益：2020年～2031年、地域別
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第4章 タイプ別セグメント

  • 世界のヘパリン原薬の売上、タイプ別（2020年～2031年）
  • 世界のヘパリン原薬の収益、タイプ別（2020年～2031年）
  • 世界のヘパリン原薬の価格、タイプ別（2020年～2031年）

用途別セグメント

  • 世界のヘパリン原薬の売上、用途別（2020年～2031年）
  • 世界のヘパリン原薬の収益、用途プ別（2020年～2031年）
  • 世界のヘパリン原薬の価格、用途別（2020年～2031年）

第5章 主要企業のプロファイル

  • Shenzhen Hepalink Pharmaceutical
  • Yantai Dongcheng Pharmaceutical
  • Pfizer
  • Bioiberica
  • Changzhou Qianhong Biopharma
  • Nanjing King-friend Biochemical Pharmaceutical
  • Hebei Changshan Biochemical Pharmaceutical
  • Qingdao Jiulong Biopharmaceutical
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Aspen Oss
  • Yino Pharma
  • Nanjing Xinbai Pharmaceutical
  • Hubei Enoray Biopharmaceutical
  • Cisen Pharmaceutical

第6章 産業チェーンと販売チャネルの分析

  • ヘパリン原薬産業チェーン分析
  • ヘパリン原薬原料供給分析
  • ヘパリン原薬製造モードとプロセス分析
  • ヘパリン原薬の販売およびマーケティング
  • ヘパリン原薬顧客分析

第7章 ヘパリン原薬市場力学

第8章 調査結果と結論

第9章 調査手法とデータソース

図表

List of Tables

  • Table 1. Global Heparin API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
  • Table 2. Global Heparin API Market Value by Application (2024 VS 2031) & (US$ Million)
  • Table 3. Global Heparin API Market Competitive Situation by Manufacturers in 2024
  • Table 4. Global Heparin API Sales (Billion Units) of Key Manufacturers (2020-2025)
  • Table 5. Global Heparin API Sales Market Share by Manufacturers (2020-2025)
  • Table 6. Global Heparin API Revenue (US$ Million) by Manufacturers (2020-2025)
  • Table 7. Global Heparin API Revenue Share by Manufacturers (2020-2025)
  • Table 8. Global Market Heparin API Average Price (US$/Billion Units) of Key Manufacturers (2020-2025)
  • Table 9. Global Key Players of Heparin API, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 10. Global Key Manufacturers of Heparin API, Manufacturing Sites & Headquarters
  • Table 11. Global Key Manufacturers of Heparin API, Product Type
  • Table 12. Global Key Manufacturers of Heparin API, Founded Date
  • Table 13. Global Manufacturers Market Concentration Ratio (CR5)
  • Table 14. Global Heparin API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Heparin API as of 2024)
  • Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
  • Table 17. Global Heparin API Sales by Region (2020-2025) & (Billion Units)
  • Table 18. Global Heparin API Sales Market Share by Region (2020-2025)
  • Table 19. Global Heparin API Sales by Region (2026-2031) & (Billion Units)
  • Table 20. Global Heparin API Sales Market Share by Region (2026-2031)
  • Table 21. Global Heparin API Revenue by Region (2020-2025) & (US$ Million)
  • Table 22. Global Heparin API Revenue Market Share by Region (2020-2025)
  • Table 23. Global Heparin API Revenue by Region (2026-2031) & (US$ Million)
  • Table 24. Global Heparin API Revenue Market Share by Region (2026-2031)
  • Table 25. North America Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 26. North America Heparin API Sales by Country (2020-2025) & (Billion Units)
  • Table 27. North America Heparin API Sales by Country (2026-2031) & (Billion Units)
  • Table 28. North America Heparin API Revenue by Country (2020-2025) & (US$ Million)
  • Table 29. North America Heparin API Revenue by Country (2026-2031) & (US$ Million)
  • Table 30. Europe Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 31. Europe Heparin API Sales by Country (2020-2025) & (Billion Units)
  • Table 32. Europe Heparin API Sales by Country (2026-2031) & (Billion Units)
  • Table 33. Europe Heparin API Revenue by Country (2020-2025) & (US$ Million)
  • Table 34. Europe Heparin API Revenue by Country (2026-2031) & (US$ Million)
  • Table 35. Asia Pacific Heparin API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 36. Asia Pacific Heparin API Sales by Region (2020-2025) & (Billion Units)
  • Table 37. Asia Pacific Heparin API Sales by Region (2026-2031) & (Billion Units)
  • Table 38. Asia Pacific Heparin API Revenue by Region (2020-2025) & (US$ Million)
  • Table 39. Asia Pacific Heparin API Revenue by Region (2026-2031) & (US$ Million)
  • Table 40. Latin America Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 41. Latin America Heparin API Sales by Country (2020-2025) & (Billion Units)
  • Table 42. Latin America Heparin API Sales by Country (2026-2031) & (Billion Units)
  • Table 43. Latin America Heparin API Revenue by Country (2020-2025) & (US$ Million)
  • Table 44. Latin America Heparin API Revenue by Country (2026-2031) & (US$ Million)
  • Table 45. Middle East and Africa Heparin API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 46. Middle East and Africa Heparin API Sales by Country (2020-2025) & (Billion Units)
  • Table 47. Middle East and Africa Heparin API Sales by Country (2026-2031) & (Billion Units)
  • Table 48. Middle East and Africa Heparin API Revenue by Country (2020-2025) & (US$ Million)
  • Table 49. Middle East and Africa Heparin API Revenue by Country (2026-2031) & (US$ Million)
  • Table 50. Global Heparin API Sales (Billion Units) by Type (2020-2025)
  • Table 51. Global Heparin API Sales (Billion Units) by Type (2026-2031)
  • Table 52. Global Heparin API Sales Market Share by Type (2020-2025)
  • Table 53. Global Heparin API Sales Market Share by Type (2026-2031)
  • Table 54. Global Heparin API Revenue (US$ Million) by Type (2020-2025)
  • Table 55. Global Heparin API Revenue (US$ Million) by Type (2026-2031)
  • Table 56. Global Heparin API Revenue Market Share by Type (2020-2025)
  • Table 57. Global Heparin API Revenue Market Share by Type (2026-2031)
  • Table 58. Global Heparin API Price (US$/Billion Units) by Type (2020-2025)
  • Table 59. Global Heparin API Price (US$/Billion Units) by Type (2026-2031)
  • Table 60. Global Heparin API Sales (Billion Units) by Application (2020-2025)
  • Table 61. Global Heparin API Sales (Billion Units) by Application (2026-2031)
  • Table 62. Global Heparin API Sales Market Share by Application (2020-2025)
  • Table 63. Global Heparin API Sales Market Share by Application (2026-2031)
  • Table 64. Global Heparin API Revenue (US$ Million) by Application (2020-2025)
  • Table 65. Global Heparin API Revenue (US$ Million) by Application (2026-2031)
  • Table 66. Global Heparin API Revenue Market Share by Application (2020-2025)
  • Table 67. Global Heparin API Revenue Market Share by Application (2026-2031)
  • Table 68. Global Heparin API Price (US$/Billion Units) by Application (2020-2025)
  • Table 69. Global Heparin API Price (US$/Billion Units) by Application (2026-2031)
  • Table 70. Shenzhen Hepalink Pharmaceutical Corporation Information
  • Table 71. Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
  • Table 72. Shenzhen Hepalink Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 73. Shenzhen Hepalink Pharmaceutical Heparin API Product
  • Table 74. Yantai Dongcheng Pharmaceutical Corporation Information
  • Table 75. Yantai Dongcheng Pharmaceutical Introduction and Business Overview
  • Table 76. Yantai Dongcheng Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 77. Yantai Dongcheng Pharmaceutical Heparin API Product
  • Table 78. Pfizer Corporation Information
  • Table 79. Pfizer Introduction and Business Overview
  • Table 80. Pfizer Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 81. Pfizer Heparin API Product
  • Table 82. Bioiberica Corporation Information
  • Table 83. Bioiberica Introduction and Business Overview
  • Table 84. Bioiberica Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 85. Bioiberica Heparin API Product
  • Table 86. Changzhou Qianhong Biopharma Corporation Information
  • Table 87. Changzhou Qianhong Biopharma Introduction and Business Overview
  • Table 88. Changzhou Qianhong Biopharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 89. Changzhou Qianhong Biopharma Heparin API Product
  • Table 90. Nanjing King-friend Biochemical Pharmaceutical Corporation Information
  • Table 91. Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
  • Table 92. Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 93. Nanjing King-friend Biochemical Pharmaceutical Heparin API Product
  • Table 94. Hebei Changshan Biochemical Pharmaceutical Corporation Information
  • Table 95. Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
  • Table 96. Hebei Changshan Biochemical Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 97. Hebei Changshan Biochemical Pharmaceutical Heparin API Product
  • Table 98. Qingdao Jiulong Biopharmaceutical Corporation Information
  • Table 99. Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
  • Table 100. Qingdao Jiulong Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 101. Qingdao Jiulong Biopharmaceutical Heparin API Product
  • Table 102. Opocrin Corporation Information
  • Table 103. Opocrin Introduction and Business Overview
  • Table 104. Opocrin Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 105. Opocrin Heparin API Product
  • Table 106. Dongying Tiandong Pharmaceutical Corporation Information
  • Table 107. Dongying Tiandong Pharmaceutical Introduction and Business Overview
  • Table 108. Dongying Tiandong Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 109. Dongying Tiandong Pharmaceutical Heparin API Product
  • Table 110. Aspen Oss Corporation Information
  • Table 111. Aspen Oss Introduction and Business Overview
  • Table 112. Aspen Oss Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 113. Aspen Oss Heparin API Product
  • Table 114. Yino Pharma Corporation Information
  • Table 115. Yino Pharma Introduction and Business Overview
  • Table 116. Yino Pharma Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 117. Yino Pharma Heparin API Product
  • Table 118. Nanjing Xinbai Pharmaceutical Corporation Information
  • Table 119. Nanjing Xinbai Pharmaceutical Introduction and Business Overview
  • Table 120. Nanjing Xinbai Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 121. Nanjing Xinbai Pharmaceutical Heparin API Product
  • Table 122. Hubei Enoray Biopharmaceutical Corporation Information
  • Table 123. Hubei Enoray Biopharmaceutical Introduction and Business Overview
  • Table 124. Hubei Enoray Biopharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 125. Hubei Enoray Biopharmaceutical Heparin API Product
  • Table 126. Cisen Pharmaceutical Corporation Information
  • Table 127. Cisen Pharmaceutical Introduction and Business Overview
  • Table 128. Cisen Pharmaceutical Heparin API Sales (Billion Units), Revenue (US$ Million), Price (US$/Billion Units) and Gross Margin (2020-2025)
  • Table 129. Cisen Pharmaceutical Heparin API Product
  • Table 130. Key Raw Materials Lists
  • Table 131. Raw Materials Key Suppliers Lists
  • Table 132. Heparin API Distributors List
  • Table 133. Heparin API Customers List
  • Table 134. Heparin API Market Trends
  • Table 135. Heparin API Market Drivers
  • Table 136. Heparin API Market Challenges
  • Table 137. Heparin API Market Restraints
  • Table 138. Research Programs/Design for This Report
  • Table 139. Key Data Information from Secondary Sources
  • Table 140. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Product Picture of Heparin API
  • Figure 2. Global Heparin API Market Value Comparison by Type (2020-2031) & (US$ Million)
  • Figure 3. Global Heparin API Revenue Market Share by Type: 2024 & 2031
  • Figure 4. Heparin Sodium API Product Picture
  • Figure 5. Heparin Calcium API Product Picture
  • Figure 6. Global Heparin API Market Value by Application (2020-2031) & (US$ Million)
  • Figure 7. Global Heparin API Revenue Market Share by Application: 2024 & 2031
  • Figure 8. UFH
  • Figure 9. LMWH
  • Figure 10. Global Heparin API Revenue, (US$ Million), 2020 VS 2024 VS 2031
  • Figure 11. Global Heparin API Market Size (2020-2031) & (US$ Million)
  • Figure 12. Global Heparin API Sales (2020-2031) & (Billion Units)
  • Figure 13. Global Heparin API Average Price (US$/Billion Units) & (2020-2031)
  • Figure 14. Heparin API Report Years Considered
  • Figure 15. Global 5 and 10 Largest Heparin API Players: Market Share by Revenue in Heparin API in 2024
  • Figure 16. Heparin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): in 2024
  • Figure 17. Global Heparin API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
  • Figure 18. United States Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 19. Canada Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 20. Germany Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 21. France Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 22. U.K. Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 23. Italy Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 24. Spain Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 25. China Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 26. Japan Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 27. India Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 28. Mexico Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 29. Brazil Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 30. Middle East Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 31. Africa Heparin API Revenue Growth Rate (2020-2031) & (US$ Million)
  • Figure 32. Global Sales Market Share of Heparin API by Type (2020-2031)
  • Figure 33. Global Revenue Market Share of Heparin API by Type (2020-2031)
  • Figure 34. Global Sales Market Share of Heparin API by Application (2020-2031)
  • Figure 35. Global Revenue Market Share of Heparin API by Application (2020-2031)
  • Figure 36. Heparin API Value Chain
  • Figure 37. Number of Pigs Worldwide from 2012 to 2025 (in million head)
  • Figure 38. Number of Pigs Worldwide in 2025, by Leading Country (in million head)
  • Figure 39. Heparin API Production Process
  • Figure 40. Channels of Distribution
  • Figure 41. Bottom-up and Top-down Approaches for This Report
  • Figure 42. Data Triangulation
  • Figure 43. Key Executives Interviewed
目次

The global Heparin API market was valued at US$ 1.23 billion in 2024 and is anticipated to reach US$ 2.30 billion by 2031, witnessing a CAGR of 7.77% during the forecast period 2025-2031.

North American market for Heparin API is estimated to increase from $ 431.49 million in 2025 to reach $ 671.33 million by 2031, at a CAGR of 7.65% during the forecast period of 2025 through 2031.

Asia-Pacific market for Heparin API is estimated to increase from $ 478.50 million in 2025 to reach $ 799.46 million by 2031, at a CAGR of 8.93% during the forecast period of 2025 through 2031.

Europe market for Heparin API is estimated to increase from $ 537.57 million in 2025 to reach $ 801.22 million by 2031, at a CAGR of 6.88% during the forecast period of 2025 through 2031.

The major global manufacturers of Heparin API include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioiberica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately 38% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Heparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin API.

The Heparin API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Heparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Shenzhen Hepalink Pharmaceutical
  • Yantai Dongcheng Pharmaceutical
  • Pfizer
  • Bioiberica
  • Changzhou Qianhong Biopharma
  • Nanjing King-friend Biochemical Pharmaceutical
  • Hebei Changshan Biochemical Pharmaceutical
  • Qingdao Jiulong Biopharmaceutical
  • Opocrin
  • Dongying Tiandong Pharmaceutical
  • Aspen Oss
  • Yino Pharma
  • Nanjing Xinbai Pharmaceutical
  • Hubei Enoray Biopharmaceutical
  • Cisen Pharmaceutical

Segment by Type

  • Heparin Sodium API
  • Heparin Calcium API

Segment by Application

  • UFH
  • LMWH

Consumption by Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of APAC
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Middle East
  • Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Heparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Heparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Heparin API Market Overview

  • 1.1 Product Definition
  • 1.2 Heparin API by Type
    • 1.2.1 Global Heparin API Market Value Comparison by Type (2024 VS 2031)
    • 1.2.2 Heparin Sodium API
    • 1.2.3 Heparin Calcium API
  • 1.3 Heparin API by Application
    • 1.3.1 Global Heparin API Market Value by Application (2024 VS 2031)
    • 1.3.2 UFH
    • 1.3.3 LMWH
  • 1.4 Global Heparin API Market Size Estimates and Forecasts
    • 1.4.1 Global Heparin API Revenue 2020-2031
    • 1.4.2 Global Heparin API Sales 2020-2031
    • 1.4.3 Global Heparin API Market Average Price (2020-2031)
  • 1.5 Assumptions and Limitations

2 Heparin API Market Competition by Manufacturers

  • 2.1 Global Heparin API Sales Market Share by Manufacturers (2020-2025)
  • 2.2 Global Heparin API Revenue Market Share by Manufacturers (2020-2025)
  • 2.3 Global Heparin API Average Price by Manufacturers (2020-2025)
  • 2.4 Global Key Players of Heparin API, Industry Ranking, 2022 VS 2023 VS 2024
  • 2.5 Global Key Manufacturers of Heparin API, Manufacturing Sites & Headquarters
  • 2.6 Global Key Manufacturers of Heparin API, Product Type
  • 2.7 Global Key Manufacturers of Heparin API, Founded Date
  • 2.8 Global Heparin API Market Competitive Situation and Trends
    • 2.8.1 Global Heparin API Market Concentration Rate
    • 2.8.2 The Global 5 and 10 Largest Heparin API Players Market Share by Revenue
    • 2.8.3 Global Heparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Heparin API Market Scenario by Region

  • 3.1 Global Heparin API Market Size by Region: 2020 Versus 2024 Versus 2031
  • 3.2 Global Heparin API Sales by Region: 2020-2031
    • 3.2.1 Global Heparin API Sales by Region: 2020-2025
    • 3.2.2 Global Heparin API Sales by Region: 2026-2031
  • 3.3 Global Heparin API Revenue by Region: 2020-2031
    • 3.3.1 Global Heparin API Revenue by Region: 2020-2025
    • 3.3.2 Global Heparin API Revenue by Region: 2026-2031
  • 3.4 North America Heparin API Market Facts & Figures by Country
    • 3.4.1 North America Heparin API Market Size by Country: 2020 VS 2024 VS 2031
    • 3.4.2 North America Heparin API Sales by Country (2020-2031)
    • 3.4.3 North America Heparin API Revenue by Country (2020-2031)
    • 3.4.4 United States
    • 3.4.5 Canada
  • 3.5 Europe Heparin API Market Facts & Figures by Country
    • 3.5.1 Europe Heparin API Market Size by Country: 2020 VS 2024 VS 2031
    • 3.5.2 Europe Heparin API Sales by Country (2020-2031)
    • 3.5.3 Europe Heparin API Revenue by Country (2020-2031)
    • 3.5.4 Germany
    • 3.5.5 France
    • 3.5.6 U.K.
    • 3.5.7 Italy
    • 3.5.8 Spain
  • 3.6 Asia Pacific Heparin API Market Facts & Figures by Region
    • 3.6.1 Asia Pacific Heparin API Market Size by Region: 2020 VS 2024 VS 2031
    • 3.6.2 Asia Pacific Heparin API Sales by Region (2020-2031)
    • 3.6.3 Asia Pacific Heparin API Revenue by Region (2020-2031)
    • 3.6.4 China
    • 3.6.5 Japan
    • 3.6.6 India
  • 3.7 Latin America Heparin API Market Facts & Figures by Country
    • 3.7.1 Latin America Heparin API Market Size by Country: 2020 VS 2024 VS 2031
    • 3.7.2 Latin America Heparin API Sales by Country (2020-2031)
    • 3.7.3 Latin America Heparin API Revenue by Country (2020-2031)
    • 3.7.4 Mexico
    • 3.7.5 Brazil
  • 3.8 Middle East and Africa Heparin API Market Facts & Figures by Country
    • 3.8.1 Middle East and Africa Heparin API Market Size by Country: 2020 VS 2024 VS 2031
    • 3.8.2 Middle East and Africa Heparin API Sales by Country (2020-2031)
    • 3.8.3 Middle East and Africa Heparin API Revenue by Country (2020-2031)
    • 3.8.4 Middle East
    • 3.8.5 Africa

4 Segment by Type

  • 4.1 Global Heparin API Sales by Type (2020-2031)
    • 4.1.1 Global Heparin API Sales by Type (2020-2025)
    • 4.1.2 Global Heparin API Sales by Type (2026-2031)
    • 4.1.3 Global Heparin API Sales Market Share by Type (2020-2031)
  • 4.2 Global Heparin API Revenue by Type (2020-2031)
    • 4.2.1 Global Heparin API Revenue by Type (2020-2025)
    • 4.2.2 Global Heparin API Revenue by Type (2026-2031)
    • 4.2.3 Global Heparin API Revenue Market Share by Type (2020-2031)
  • 4.3 Global Heparin API Price by Type (2020-2031)

Segment by Application

  • 4.4 Global Heparin API Sales by Application (2020-2031)
    • 4.4.1 Global Heparin API Sales by Application (2020-2025)
    • 4.4.2 Global Heparin API Sales by Application (2026-2031)
    • 4.4.3 Global Heparin API Sales Market Share by Application (2020-2031)
  • 4.5 Global Heparin API Revenue by Application (2020-2031)
    • 4.5.1 Global Heparin API Revenue by Application (2020-2025)
    • 4.5.2 Global Heparin API Revenue by Application (2026-2031)
    • 4.5.3 Global Heparin API Revenue Market Share by Application (2020-2031)
  • 4.6 Global Heparin API Price by Application (2020-2031)

5 Key Company Profiled

  • 5.1 Shenzhen Hepalink Pharmaceutical
    • 5.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information
    • 5.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
    • 5.1.3 Shenzhen Hepalink Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.1.4 Shenzhen Hepalink Pharmaceutical Heparin API Products Offered
  • 5.2 Yantai Dongcheng Pharmaceutical
    • 5.2.1 Yantai Dongcheng Pharmaceutical Corporation Information
    • 5.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview
    • 5.2.3 Yantai Dongcheng Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.2.4 Yantai Dongcheng Pharmaceutical Heparin API Products Offered
  • 5.3 Pfizer
    • 5.3.1 Pfizer Corporation Information
    • 5.3.2 Pfizer Introduction and Business Overview
    • 5.3.3 Pfizer Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.3.4 Pfizer Heparin API Products Offered
  • 5.4 Bioiberica
    • 5.4.1 Bioiberica Corporation Information
    • 5.4.2 Bioiberica Introduction and Business Overview
    • 5.4.3 Bioiberica Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.4.4 Bioiberica Heparin API Products Offered
  • 5.5 Changzhou Qianhong Biopharma
    • 5.5.1 Changzhou Qianhong Biopharma Corporation Information
    • 5.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview
    • 5.5.3 Changzhou Qianhong Biopharma Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.5.4 Changzhou Qianhong Biopharma Heparin API Products Offered
  • 5.6 Nanjing King-friend Biochemical Pharmaceutical
    • 5.6.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information
    • 5.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
    • 5.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin API Products Offered
  • 5.7 Hebei Changshan Biochemical Pharmaceutical
    • 5.7.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
    • 5.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
    • 5.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin API Products Offered
  • 5.8 Qingdao Jiulong Biopharmaceutical
    • 5.8.1 Qingdao Jiulong Biopharmaceutical Corporation Information
    • 5.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
    • 5.8.3 Qingdao Jiulong Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.8.4 Qingdao Jiulong Biopharmaceutical Heparin API Products Offered
  • 5.9 Opocrin
    • 5.9.1 Opocrin Corporation Information
    • 5.9.2 Opocrin Introduction and Business Overview
    • 5.9.3 Opocrin Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.9.4 Opocrin Heparin API Products Offered
  • 5.10 Dongying Tiandong Pharmaceutical
    • 5.10.1 Dongying Tiandong Pharmaceutical Corporation Information
    • 5.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview
    • 5.10.3 Dongying Tiandong Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.10.4 Dongying Tiandong Pharmaceutical Heparin API Products Offered
  • 5.11 Aspen Oss
    • 5.11.1 Aspen Oss Corporation Information
    • 5.11.2 Aspen Oss Introduction and Business Overview
    • 5.11.3 Aspen Oss Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.11.4 Aspen Oss Heparin API Products Offered
  • 5.12 Yino Pharma
    • 5.12.1 Yino Pharma Corporation Information
    • 5.12.2 Yino Pharma Introduction and Business Overview
    • 5.12.3 Yino Pharma Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.12.4 Yino Pharma Heparin API Products Offered
  • 5.13 Nanjing Xinbai Pharmaceutical
    • 5.13.1 Nanjing Xinbai Pharmaceutical Corporation Information
    • 5.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview
    • 5.13.3 Nanjing Xinbai Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.13.4 Nanjing Xinbai Pharmaceutical Heparin API Products Offered
  • 5.14 Hubei Enoray Biopharmaceutical
    • 5.14.1 Hubei Enoray Biopharmaceutical Corporation Information
    • 5.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview
    • 5.14.3 Hubei Enoray Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.14.4 Hubei Enoray Biopharmaceutical Heparin API Products Offered
  • 5.15 Cisen Pharmaceutical
    • 5.15.1 Cisen Pharmaceutical Corporation Information
    • 5.15.2 Cisen Pharmaceutical Introduction and Business Overview
    • 5.15.3 Cisen Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
    • 5.15.4 Cisen Pharmaceutical Heparin API Products Offered

6 Industry Chain and Sales Channels Analysis

  • 6.1 Heparin API Industry Chain Analysis
  • 6.2 Heparin API Raw Material Supply Analysis
    • 6.2.1 Key Raw Materials
    • 6.2.2 Raw Materials Key Suppliers
  • 6.3 Heparin API Production Mode & Process Analysis
  • 6.4 Heparin API Sales and Marketing
    • 6.4.1 Heparin API Sales Channels
    • 6.4.2 Heparin API Distributors
  • 6.5 Heparin API Customer Analysis

7 Heparin API Market Dynamics

  • 7.1 Heparin API Industry Trends
  • 7.2 Heparin API Market Drivers
  • 7.3 Heparin API Market Challenges
  • 7.4 Heparin API Market Restraints

8 Research Findings and Conclusion

9 Methodology and Data Source

  • 9.1 Methodology/Research Approach
    • 9.1.1 Research Programs/Design
    • 9.1.2 Market Size Estimation
    • 9.1.3 Market Breakdown and Data Triangulation
  • 9.2 Data Source
    • 9.2.1 Secondary Sources
    • 9.2.2 Primary Sources
  • 9.3 Author Details
  • 9.4 Disclaimer 107